RT @NDTsocial: Common chronic conditions do not affect performance of cell cycle arrest #biomarkers for risk stratification of #AKI https:/…
RT @NDTsocial: Common chronic conditions do not affect performance of cell cycle arrest #biomarkers for risk stratification of #AKI https:/…
Common chronic conditions do not affect performance of cell cycle arrest #biomarkers for risk stratification of #AKI https://t.co/fhiltdrDgX https://t.co/i2iEyUZcZG
Biomarkers may be the future of diagnosing #AKI, but will other conditions muddy the waters? https://t.co/FEC3pjTLOC https://t.co/U6OpKlFLG9
RT @CCCNPitt: Is the sum greater than the parts? Treating #AKI in patients with many comorbid conditions https://t.co/PuTWBzqP1D https://t.…
Is the sum greater than the parts? Treating #AKI in patients with many comorbid conditions https://t.co/PuTWBzqP1D https://t.co/QUl6R16s7Q
@NDTsocial high scoring paper - cell cycle arrest biomarkers for #AcuteKidneyInjury https://t.co/aNV9wNdjE2 https://t.co/gsXXyfBsbS
The more the merrier? How do #chronic comorbid conditions impair the function of #cell cycle arrest biomarkers? https://t.co/U2RMNGc9qf
Common chronic conditions do not affect performance of cell cycle arrest biomarkers for risk stratification of #AKI https://t.co/Jkj7aTh4OI